Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work With Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Breast Cancer Genetic Testing Expands Through NHS Pathway
September 2026
An NHS programme demonstrated the feasibility of clinician-light breast cancer genetic testing, identifying germline pathogenic variants in 4.7% of patients.
Read more
28 Sep 2026
Breast Cancer Genetic Testing Expands Through NHS Pathway
An NHS programme demonstrated the feasibility of clinician-light breast cancer genetic testing, identifying germline pathogenic variants in 4.7% of patients.
25 Sep 2026
Pancreatic Cancer Mortality Remains Unequal Across Japan
A nationwide study found that pancreatic cancer mortality remained associated with socioeconomic deprivation in Japan, particularly among men aged under 75 years.
25 Sep 2026
New Rapid Brain Tumour Test Cuts Diagnosis Time to Hours
A rapid genomic test could identify brain tumour types within hours, helping doctors plan surgery and treatment sooner.
25 Sep 2026
Blood Test May Predict Cancer Risk Years Before Diagnosis
Blood DNA methylation patterns may identify increased prostate cancer risk up to eight years before diagnosis.
23 Sep 2026
Wildfire Smoke Linked to Poorer Lung Cancer Survival
Long-term wildfire smoke exposure was associated with poorer survival amongst older patients with lung cancer.
20 Sep 2026
Glioma Metabolite Drives Neuronal Activity and Tumour Growth
Glioma-derived GAA stimulates surrounding neurons and promotes tumour growth, revealing a potential treatment target.
18 Sep 2026
Mobile Cancer Testing Defines Safer Outreach Pathways
A qualitative study developed an implementation-aware Target Product Profile for mobile cancer testing, identifying 42 attributes and key handover requirements.
16 Sep 2026
mRNA Nanoparticles Reprogramme Tumour Immune Environment
Targeted mRNA nanoparticles reprogrammed tumour-associated macrophages to support antitumour T-cell activity.
Loading posts...
1
2
3
…
74
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View